IRVINE, Calif., June 17 Edwards LifesciencesCorporation (NYSE: EW), a world leader in products and technologies to treatadvanced cardiovascular disease, is scheduled to participate in the 18thAnnual Wachovia Nantucket Equity Conference at the White Elephant Hotel inNantucket, Massachusetts on Tuesday, June 24, 2008.
Thomas M. Abate, Edwards Lifesciences' corporate vice president, chieffinancial officer & treasurer, is scheduled to speak to conference attendeesat 2:30 p.m. ET. A live webcast of the presentation will be available to allinterested parties on the Edwards Lifesciences investor relations website athttp://www.edwards.com/InvestorRelations/EventCalendar.htm. An archivedversion of the webcast will be available later that day on the Edwardsinvestor relations website in the News and Events section.
About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valvesand hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards treatsadvanced cardiovascular disease with its market-leading heart valve therapies,and critical care and vascular technologies. In 2008, Edwards celebrates 50years of partnering with clinicians to develop life-saving innovations. Thecompany's global brands, which are sold in approximately 100 countries,include CardioVations, the CardioVations logo, Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz. Additional companyinformation can be found at http://www.edwards.com.
Edwards is a trademark of Edwards Lifesciences Corporation. EdwardsLifesciences, the stylized E logo, CardioVations, the CardioVations logo,Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, PERIMOUNT Magna andSwan-Ganz are trademarks of Edwards Lifesciences Corporation and areregistered in the United States Patent and Trademark Office.
SOURCE Edwards Lifesciences Corporation